Back to Journals » Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (582)
- Volume 11, 2024 (58)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Journal Articles:
- Advanced Radiation Therapy and Radiobiology for Hepatocellular Carcinoma (5)
- Insights and Innovations in Imaging for Hepatocellular Carcinoma: Advancing Diagnosis and Management (3)
- The Emerging Multiple Modality Treatment Based on Systemic Therapy for Hepatocellular Carcinoma (HCC) (11)
- Combination of Immune Checkpoint Inhibitors and Locoregional Therapy of Hepatocellular Carcinoma: Hype or Hope (1)
Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis
Wen Y, Lu L, Mei J, Ling Y, Guan R, Lin W, Wei W, Guo R
Journal of Hepatocellular Carcinoma 2024, 11:665-678
Published Date: 4 April 2024
Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis
Nikzad N, Fuentes DT, Roach M, Chowdhury T, Cagley M, Badawy M, Elkhesen A, Hassan M, Elsayes KM, Beretta L, Koay EJ, Jalal PK
Journal of Hepatocellular Carcinoma 2024, 11:595-606
Published Date: 20 March 2024
Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for Hepatocellular Carcinoma
Hall JT, Moon AM, Young M, Tan X, Darawsheh R, Danquah F, Tepper JE, Yanagihara TK
Journal of Hepatocellular Carcinoma 2024, 11:443-454
Published Date: 5 March 2024
Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma
Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, Zhu X
Journal of Hepatocellular Carcinoma 2024, 11:477-488
Published Date: 4 March 2024
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy
Li W, Zheng Z, Wang J, Wu T, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z
Journal of Hepatocellular Carcinoma 2024, 11:463-475
Published Date: 4 March 2024
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy
Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J
Journal of Hepatocellular Carcinoma 2024, 11:305-316
Published Date: 8 February 2024
PD1 and TIM3 Expression is Associated with Very Early Hepatocellular Carcinoma Recurrence After Percutaneous Thermal Ablation
Ghelfi J, Macek Jilkova Z, Sengel C, Brusset B, Teyssier Y, Costentin C, Mercey-Ressejac M, Dumolard L, Manceau M, Mathieu E, Bricault I, Decaens T
Journal of Hepatocellular Carcinoma 2024, 11:39-50
Published Date: 9 January 2024
Predicting T Cell-Inflamed Gene Expression Profile in Hepatocellular Carcinoma Based on Dynamic Contrast-Enhanced Ultrasound Radiomics
Wang Y, Weng W, Liang R, Zhou Q, Hu H, Li M, Chen L, Chen S, Peng S, Kuang M, Xiao H, Wang W
Journal of Hepatocellular Carcinoma 2023, 10:2291-2303
Published Date: 18 December 2023
An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma
Peng Y, Wu X, Zhang Y, Yin Y, Chen X, Zheng D, Wang J
Journal of Hepatocellular Carcinoma 2023, 10:2305-2321
Published Date: 18 December 2023
Implanting Iodine-125 Seed Strand Inside the Portal Vein Stent: An Improved Approach to Endovascular Brachytherapy for Treatment of Patients with Hepatocellular Carcinoma and Main Portal Vein Tumor Thrombus
Zhang L, Wang J, Li Y, Hou L, Xia J, Shen J
Journal of Hepatocellular Carcinoma 2023, 10:2187-2196
Published Date: 6 December 2023
Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy
Zheng Z, Wang J, Wu T, He M, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z
Journal of Hepatocellular Carcinoma 2023, 10:2117-2132
Published Date: 30 November 2023
Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre
Li G, Zhao Y, Li K, Yang S, Xiang C, Song J, Yang Y, Li G, Dong J
Journal of Hepatocellular Carcinoma 2023, 10:2037-2048
Published Date: 9 November 2023
The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
Hsu HM, Tsai HI, Lee WC, Wang CC, Yu MC, Lin SM, Lin CY, Wu CH, Lee CW
Journal of Hepatocellular Carcinoma 2023, 10:1873-1880
Published Date: 24 October 2023
MRI Features for Predicting Microvascular Invasion and Postoperative Recurrence in Hepatocellular Carcinoma Without Peritumoral Hypointensity
Chen Z, Li X, Zhang Y, Yang Y, Zhang Y, Zhou D, Yang Y, Zhang S, Liu Y
Journal of Hepatocellular Carcinoma 2023, 10:1595-1608
Published Date: 25 September 2023
Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
Ouyang J, Wang Z, Yuan K, Yang Y, Zhou Y, Li Q, Yang N, Zhao H, Zhao H, Zhou J
Journal of Hepatocellular Carcinoma 2023, 10:1465-1477
Published Date: 6 September 2023
Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study
Chang X, Wu H, Ning S, Li X, Xie Y, Shao W, Yu J
Journal of Hepatocellular Carcinoma 2023, 10:1497-1509
Published Date: 6 September 2023
Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization
Chen C, Liu J, Gu Z, Sun Y, Lu W, Liu X, Chen K, Ma T, Zhao S, Zhao H
Journal of Hepatocellular Carcinoma 2023, 10:1295-1308
Published Date: 8 August 2023
Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe
Liu J, Sun M, Fang K, Wang J, Ma B, Song L, Liu T, Tang M, Wang K, Xia Y
Journal of Hepatocellular Carcinoma 2023, 10:997-1007
Published Date: 28 June 2023
Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis
De la Garza-Ramos C, Montazeri SA, Musto KR, Kapp MD, Lewis AR, Frey G, Paz-Fumagalli R, Ilyas S, Harnois DM, Majeed U, Patel T, Toskich B
Journal of Hepatocellular Carcinoma 2023, 10:987-996
Published Date: 23 June 2023
Simultaneous and Sequential Use of Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Real-World Practice in China
Li J, Huang L, Ge C, Zhu X, Qiu M, Chen C, Wei S, Yan Y
Journal of Hepatocellular Carcinoma 2023, 10:949-958
Published Date: 20 June 2023